Health eMatters IMPACT Series
Bringing EDI to Clinical Trials
April 25-26, 2024 — Toronto, Ontario
Driven and organized by Health eMatters, this IMPACT Conference creates a space for advocates, pharma, and healthcare providers to join forces to find real and implementable solutions to improve EDI in clinical research practices.
When you bring everyone to the table, at the same time, we have a real opportunity to drive change.
Various logistical barriers in current clinical trial accrual procedures in Canada, and worldwide, have a negative impact on diverse population representation, leading to possible effects on real world outcomes, and inequitable access to innovative and life-saving medicines for patients. In recent years, much attention has been placed on understanding what these barriers are, and how it is affecting Equity, Diversity and
Inclusion (EDI) in clinical trial participation. Although several solutions have been tested, implementation of these solutions have not resulted in impactful systemic changes due to complex operational structures, system rigidity, and siloed workflows. Change is difficult but necessary to improve clinical trial execution and exceptional patient care, especially in cancer.
In April 2024, a two-day conference organized by Myeloma Canada, a non-profit patient organization, gathered representatives from all groups involved in clinical trial procedures: pharmaceutical sponsors, clinical research organizations (CROs), researchers, clinical research nurses, hospital administrators, and advocacy groups anchored by patients to workshop through solutions for operationalizing EDI in clinical trial accrual.
To learn more, read the report: Promoting Equity, Diversity and Inclusion (EDI) in Clinical Trial Accruals: A Change Management Workshop in Operationalizing Implementation
© 2021 Health eMatters | Brought to you by Myeloma Canada 
| Site by Phil